Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2012

Oct 3, 2012

33431_dirs_2012-10-03_0a2e3e4e-588d-4fc3-9689-04ff240bb05f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-10-01

Reporting Person: SKINNER GREGORY S (VP Finance and Admin & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-10-01 Common Stock X 5000 $6.79 Acquired 11661 Indirect
2012-10-01 Common Stock X 2250 $6.22 Acquired 13911 Indirect
2012-10-01 Common Stock X 1625 $5.63 Acquired 15536 Indirect
2012-10-01 Common Stock S 8875 $11.51 Disposed 6661 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-10-01 Nonqualified Stock Option (Right to Buy) $6.79 X 5000 Disposed 2014-02-12 Common Stock (5000) Indirect
2012-10-01 Incentive Stock Option (Right to Buy) $6.22 X 2250 Disposed 2016-05-21 Common Stock (2250) Indirect
2012-10-01 Incentive Stock Option (Right to Buy) $5.63 X 1625 Disposed 2017-05-26 Common Stock (1625) Indirect